ÂÜÀòÂÒÂ×

Kasper Oktavio Schweitz holds an EMBA and a PhD in Physics, with extensive experience in leadership and R&D within the medical technology sector. Currently serving as President at HemoCue AB, a Danaher company, since November 2022, Kasper has previously been a member of VL14, The Danish Management Society, since December 2019, and spent over 16 years at Radiometer in various leadership roles, including GM/VP of the Blood Gas Business and Vice President of Global R&D. Kasper has a proven track record in sensor technology development, strategy execution, and organizational management, leading teams to achieve operational efficiency and innovation. Educational credentials include an MBA from Copenhagen Business School and substantial training in industrial and technical disciplines.